Register Login

INMED PHARMACEUTICALS INC. (INM)

SymbolINM
NameINMED PHARMACEUTICALS INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
AddressSUITE 1445 ¿ 885 WEST GEORGIA STREET, VANCOUVER, British Columbia, V6C 3E8, Canada
Telephone+1 604 669-7207
Fax—
Email—
Websitehttps://www.inmedpharma.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001728328
Description

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.

Additional info from NASDAQ:
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.

2026-08-14 22:12

New Form SCHEDULE 13G - InMed Pharmaceuticals Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-352958 <b>Size:</b> 154 KB

Read more
2026-07-22 20:28

(70% Positive) INMED PHARMACEUTICALS INC. (INM) Announces Business Combination

Read more
2026-07-22 17:32

New Form 425 - InMed Pharmaceuticals Inc. <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0001213900-26-080423 <b>Size:</b> 23 MB

Read more
2026-07-22 17:30

New Form 425 - InMed Pharmaceuticals Inc. <b>Filed:</b> 2026-07-22 <b>AccNo:</b> 0001213900-26-080417 <b>Size:</b> 113 KB

Read more
2026-07-20 17:27

New Form 425 - InMed Pharmaceuticals Inc. <b>Filed:</b> 2026-07-20 <b>AccNo:</b> 0001213900-26-079635 <b>Size:</b> 270 KB

Read more
2026-07-17 23:29

ADAR1 Capital Management, LLC 🟢 acquired 1.0K shares of InMed Pharmaceuticals Inc. (INM) at $1.55 Transaction Date: Jul 15, 2026 | Filing ID: 000010

Read more
2026-07-17 01:58

Vivo Opportunity, LLC 🟢 acquired 20.5K shares of InMed Pharmaceuticals Inc. (INM) at $1.55 Transaction Date: Jul 14, 2026 | Filing ID: 078891

Read more
2026-07-06 23:14

InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4

Read more
2026-07-02 23:02

Vivo Opportunity, LLC 🟢 acquired 6.6K shares of InMed Pharmaceuticals Inc. (INM) at $1.55 Transaction Date: Jun 30, 2026 | Filing ID: 075144

Read more
2026-06-11 01:14

Vivo Opportunity, LLC 🟢 acquired 249.2K shares of InMed Pharmaceuticals Inc. (INM) at $1.69 Transaction Date: May 20, 2026 | Filing ID: 067505

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT04908215 INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa Phase2 Epidermolysis Bullosa Simplex Completed 2021-12-28 2023-04-19 ClinicalTrials.gov
Total clinical trials: 1
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
Vehicle Cream Other Phase PHASE2 Epidermolysis Bullosa Simplex COMPLETED NCT04908215
INM-755 (cannabinol) cream Other Phase PHASE2 Epidermolysis Bullosa Simplex COMPLETED NCT04908215
KDT501 DRUG Phase PHASE2 Diabetes Mellitus, Type 2 COMPLETED NCT02444910
Vehicle Cream DRUG Phase PHASE2 Epidermolysis Bullosa Simplex COMPLETED NCT04908215
INM-755 (cannabinol) cream DRUG Phase PHASE2 Epidermolysis Bullosa Simplex COMPLETED NCT04908215
Total products: 5